Disclosure 0001193125-26-390510-2

SEC FORM 4

$68,864.24

Amylyx Pharmaceuticals, Inc. (AMLX)

Sale of 2,081 shares at $33.0919 per share.

Reporting Person Bedrosian Camille L · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-390510 · filed 2026-09-14 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Amylyx Pharmaceuticals, Inc. (AMLX)." Disclosed 2026-09-14. https://desqlong.com/cards/0001193125-26-390510-2 (retrieved 2026-09-26).